Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Evolutionary history of sickle-cell mutation: implications for global genetic medicine

Domain:

healthcare

Record type:

paper
Creator:
KevAmb
Publisher:
Oxf
Host:
Abstract Resistance afforded by the sickle-cell trait against severe malaria has led to high frequencies of the sickle-cell mutation [HBB; c.20T>A, p.Glu6Val; OMIM: 141900 (HBB-βS)] in most parts of Africa. High-coverage sequencing and genotype data have now confirmed the single African origin of the sickle-cell gene variant [HBB; c.20T>A, p.Glu6Val; OMIM: 141900 (HBB-βS)]. Nevertheless, the classical HBB-like genes cluster haplotypes remain a rich source of HBB-βS evolutionary information. The overlapping distribution of HBB-βS and other disease-associated variants means that their evolutionary genetics must be investigated concurrently. In this review: (1) we explore the evolutionary history of HBB-βS and its implications in understanding human migration within and out of Africa: e.g. HBB haplotypes and recent migration paths of the Bantu expansion, occurrence of ~7% of the Senegal haplotype in Angola reflecting changes in population/SCD dynamics, and existence of all five classical HBB haplotype in Cameroon and Egypt suggesting a much longer presence of HBB-βS in these regions; (2) we discuss the time estimates of the emergence of HBB-βS in Africa and finally, (3) we discuss implications for genetic medicine in understanding complex epistatic interactions between HBB-βS and other gene variants selected under environmental pressure in Africa e.g. variants in HBB, HBA, G6PD, APOL1, APOE, OSBPL10 and RXRA.

Visit

doi.org

Licenses

http://creativecommons.org/licenses/by/4.0/

Similar

Precision Medicine and Sickle Cell DiseaseGenetic modifiers of long‐term survival in sickle cell anemiaMethylene tetrahydrofolate reductase gene mutation in sickle cell anaemia patients in Lagos, NigeriaGenetic Variation In MYH9 Is Associated with Sickle Cell Disease NephropathyEnhancing Genetic Medicine: Rapid and Cost-Effective Molecular Diagnosis for a GJB2 Founder Mutation for Hearing Impairment in GhanaGenetic Analyses in the Uganda Sickle Surveillance Study: Modifiers of Sickle Cell Anemia and Identification of Hemoglobin Variants

Precision Medicine and Sickle Cell Disease

International audience

Genetic modifiers of long‐term survival in sickle cell anemia

Abstract Background Sickle cell anemia (SCA) is a clinically heterogeneous, monogenic disorder. M

Methylene tetrahydrofolate reductase gene mutation in sickle cell anaemia patients in Lagos, Nigeria

Genetic Variation In MYH9 Is Associated with Sickle Cell Disease Nephropathy

Abstract Abstract 1648 Background:

Enhancing Genetic Medicine: Rapid and Cost-Effective Molecular Diagnosis for a GJB2 Founder Mutation for Hearing Impairment in Ghana

In Ghana, gap-junction protein β 2 (GJB2) variants account for about 25.9% of familial hearing impai

Genetic Analyses in the Uganda Sickle Surveillance Study: Modifiers of Sickle Cell Anemia and Identification of Hemoglobin Variants

Abstract Introduction: The Uganda Sickle Surveillance Study (US3)